İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - capsules hard - 67 milligram - fibrates - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate. - capsule, hard. - 200mg - serum lipid reducing agents/cholesterol and triglyceride reducers/fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following: - treatment of severe hypertriglyceridaemia with or without low hdl cholesterol. - mixed hyperlipidaemia when a statin is contraindicated or not tolerated. - mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - fenofibrate - film coated tablet - 145 milligram - fibrates - serum lipid reducing agents / cholesterol and triglycerides reducers / fibrates - it is indicated as an adjunct to diet and other non-pharmacological treatment (e.g. exercise, weight reduction) for the following:
treatment of severe hypertriglyceridaemia with or without low hdl cholesterol.
mixed hyperlipidaemia when a statin is contraindicated or not tolerated.
mixed hyperlipidaemia in patients at high cardiovascular risk in addition to a statin when triglycerides and hdl cholesterol are not adequately controlled.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine hydrochloride - tablets - 8 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine hydrochloride - tablets - 16 milligram - antivertigo preparations - anti-vertigo preparations - vertigo, tinnitus and hearing loss associated with ménière's syndrome.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine dihydrochloride - tablets - 8 milligram - antivertigo preparations

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - betahistine dihydrochloride - tablets - 16 milligram - antivertigo preparations

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 1 mg, 10 m milligram - progestogens and estrogens, sequential preparations

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol, dydrogesterone - film coated tablet - 0.5/2.5 milligram - progestogens and estrogens, fixed combinations